Pneumocystis carinii infection in the HIV-seropositive patient. 1994

A A Moe, and W D Hardy
Center for Clinical AIDS Research and Education, University of California School of Medicine, Los Angeles.

In this article, Pneumocystis carinii pneumonia (PCP) in persons with AIDS is described with regard to its epidemiology, pathogenesis, presentation, treatment, and prophylaxis. The changing epidemiologic patterns of PCP from 1981 to 1993 are diagrammed. Atypical and classical presentations of pre-AIDS, including extrapulmonary Pneumocystis, are discussed. Diagnostic strategies are outlined, giving algorithms for the most efficient means of diagnosing PCP. Various intravenous and oral treatment options for pneumonia, the use of adjunctive corticosteroids, and comparison of various prophylactic regimens are also presented in this article.

UI MeSH Term Description Entries
D011020 Pneumonia, Pneumocystis A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis. P carinii Pneumonia,P. carinii Pneumonia,P. jirovecii Pneumonia,PCP Pneumonia,Pneumocystis Pneumonia,Pneumocystosis,Pneumonia, Interstitial Plasma Cell,PCP Infection,Pneumocystis carinii Pneumonia,Pneumocystis jirovecii Pneumonia,Pneumonia, Pneumocystis carinii,Infection, PCP,P carinii Pneumonias,P. carinii Pneumonias,P. jirovecii Pneumonias,PCP Infections,PCP Pneumonias,Pneumocystis Pneumonias,Pneumocystoses,Pneumonia, P carinii,Pneumonia, P. carinii,Pneumonia, P. jirovecii,Pneumonia, PCP,Pneumonia, Pneumocystis jirovecii,Pneumonias, PCP
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016720 Pneumocystis Infections Infections with species in the genus PNEUMOCYSTIS, a fungus causing interstitial plasma cell pneumonia (PNEUMONIA, PNEUMOCYSTIS) and other infections in humans and other MAMMALS. Immunocompromised patients, especially those with AIDS, are particularly susceptible to these infections. Extrapulmonary sites are rare but seen occasionally. P carinii Infection,P jirovecii Infection,P. carinii Infection,P. jirovecii Infection,Pneumocystis carinii Infection,Pneumocystis jirovecii Infection,Pneumocystis carinii Infections,Infection, P carinii,Infection, P jirovecii,Infection, P. carinii,Infection, P. jirovecii,Infection, Pneumocystis,Infection, Pneumocystis jirovecii,P carinii Infections,P jirovecii Infections,P. carinii Infections,P. jirovecii Infections,Pneumocystis Infection,Pneumocystis jirovecii Infections
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related

Related Publications

A A Moe, and W D Hardy
February 2007, International journal of STD & AIDS,
A A Moe, and W D Hardy
April 1989, European journal of pediatrics,
A A Moe, and W D Hardy
January 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene,
A A Moe, and W D Hardy
January 1992, Vestnik Rossiiskoi akademii meditsinskikh nauk,
A A Moe, and W D Hardy
January 1998, Revista clinica espanola,
A A Moe, and W D Hardy
April 1998, Enfermedades infecciosas y microbiologia clinica,
Copied contents to your clipboard!